Range
2.19 - 2.28
Vol / Avg.
297.8K/10M
Div / Yield
-
52 Wk
0.76 - 5.85
Mkt Cap
21.5M
Payout Ratio
-
Open
2.27
P/E
-
EPS
-0.13
Shares
9.7M
Outstanding
9.7M
Total Float
9M
Sector: Health Care.Industry: Biotechnology
Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-12
REV
Q2 2021Est.ActualSurprise
EPS-0.160-0.130 0.0300
REV190.000K287.603K97.603K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
XBIOXenetic Biosciences-0.89%21.5M

Xenetic Biosciences Questions & Anwsers

Q

How do I buy Xenetic Biosciences (XBIO) stock?

A

You can purchase shares of Xenetic Biosciences (NASDAQ: XBIO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Xenetic Biosciences's (XBIO) competitors?

Q

What is the target price for Xenetic Biosciences (XBIO) stock?

A

The latest price target for Xenetic Biosciences (NASDAQ: XBIO) was reported by HC Wainwright & Co. on January 11, 2021. The analyst firm set a price target for 5.00 expecting XBIO to rise to within 12 months (a possible 125.23% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Xenetic Biosciences (XBIO)?

A

The stock price for Xenetic Biosciences (NASDAQ: XBIO) is $2.22 last updated Fri Sep 24 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Xenetic Biosciences (XBIO) pay a dividend?

A

There are no upcoming dividends for Xenetic Biosciences.

Q

When is Xenetic Biosciences (NASDAQ:XBIO) reporting earnings?

A
Xenetic Biosciences’s Q3 earnings are confirmed for after-market on November 12, 2021.
Q

Is Xenetic Biosciences (XBIO) going to split?

A

There is no upcoming split for Xenetic Biosciences.

Q

What sector and industry does Xenetic Biosciences (XBIO) operate in?

A

Xenetic Biosciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.